The production and sales of generics that lost Eliquis(Apixaban)' patent dispute were halted. According to the drug distribution industry on the 16th, generic for Eliquis companies stopped producing and selling items at once after the Supreme Court ruling. There is some inventory that has been passed to wholesalers.

Generics for Eliquis have been released since June 2019 ▲Chong Kun Dang's Liquisia ▲Yuhan’s Yuhan Apixaban ▲Samjin's Elxaban ▲Hanmi’s Apixban ▲Yooyoung’s Yupix, and ▲Huons’ Apiquis. The Supreme Court overturned the court case on the 8th and sided with the patent holder, BMS. Distribution was stopped in preparation for compensation for damages in the final judgment.